201 related articles for article (PubMed ID: 21104860)
21. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
22. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development.
Wang DZ; Valdez MR; McAnally J; Richardson J; Olson EN
Development; 2001 Nov; 128(22):4623-33. PubMed ID: 11714687
[TBL] [Abstract][Full Text] [Related]
23. Identification of HZF1 as a novel target gene of the MEF2 transcription factor.
Liu X; Jin EZ; Zhi JX; Li XQ
Mol Med Rep; 2011; 4(3):465-9. PubMed ID: 21468593
[TBL] [Abstract][Full Text] [Related]
24. Functional gene expression analysis of tissue-specific isoforms of Mef2c.
Sekiyama Y; Suzuki H; Tsukahara T
Cell Mol Neurobiol; 2012 Jan; 32(1):129-39. PubMed ID: 21842419
[TBL] [Abstract][Full Text] [Related]
25. Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model.
Jeng SF; Rau CS; Liliang PC; Wu CJ; Lu TH; Chen YC; Lin CJ; Hsieh CH
J Neurotrauma; 2009 Dec; 26(12):2345-53. PubMed ID: 19586368
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation.
Sebastian S; Faralli H; Yao Z; Rakopoulos P; Palii C; Cao Y; Singh K; Liu QC; Chu A; Aziz A; Brand M; Tapscott SJ; Dilworth FJ
Genes Dev; 2013 Jun; 27(11):1247-59. PubMed ID: 23723416
[TBL] [Abstract][Full Text] [Related]
27. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).
Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C
Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042
[TBL] [Abstract][Full Text] [Related]
28. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
29. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
30. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
Ridgeway AG; Wilton S; Skerjanc IS
J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
[TBL] [Abstract][Full Text] [Related]
31. Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function.
Wyce A; Bai Y; Nagpal S; Thompson CC
Mol Endocrinol; 2010 Aug; 24(8):1665-74. PubMed ID: 20610535
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.
Wang YX; Qian LX; Liu D; Yao LL; Jiang Q; Yu Z; Gui YH; Zhong TP; Song HY
Cardiovasc Res; 2007 May; 74(2):290-303. PubMed ID: 17367767
[TBL] [Abstract][Full Text] [Related]
33. Monitoring the interaction between DNA and a transcription factor (MEF2A) using fluorescence correlation spectroscopy.
Octobre G; Lemercier C; Khochbin S; Robert-Nicoud M; Souchier C
C R Biol; 2005 Dec; 328(12):1033-40. PubMed ID: 16314281
[TBL] [Abstract][Full Text] [Related]
34. CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene.
Smith JA; Kohn TA; Chetty AK; Ojuka EO
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E698-704. PubMed ID: 18647882
[TBL] [Abstract][Full Text] [Related]
35. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
Savkur RS; Philips AV; Cooper TA
Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
[TBL] [Abstract][Full Text] [Related]
36. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment.
Wu Y; Dey R; Han A; Jayathilaka N; Philips M; Ye J; Chen L
J Mol Biol; 2010 Mar; 397(2):520-33. PubMed ID: 20132824
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
38. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis.
Subramanian SV; Nadal-Ginard B
Mech Dev; 1996 Jun; 57(1):103-12. PubMed ID: 8817457
[TBL] [Abstract][Full Text] [Related]
39. Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2C.
Al Madhoun AS; Mehta V; Li G; Figeys D; Wiper-Bergeron N; Skerjanc IS
EMBO J; 2011 May; 30(12):2477-89. PubMed ID: 21556048
[TBL] [Abstract][Full Text] [Related]
40. SUMO-1 modification of MEF2A regulates its transcriptional activity.
Riquelme C; Barthel KK; Liu X
J Cell Mol Med; 2006; 10(1):132-44. PubMed ID: 16563226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
